Physician profile
Jon Boyd Poulson
NPI 1801832506
$472.47
in general payments reported to CMS, 2019-2025
8 companies · $159 in 2025
The $159 reported for 2025 was more than what 85% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $167 · 2023: $20.15 · 2024: $20.24 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180 · Education: $20.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.56 |
| Education | $20.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $193.60 | 2021-2025 | Bridion |
| Mindray Ds USA, INC. | $85.96 | 2025 | A7 Anesthesia System |
| Chiesi USA, INC. | $54.97 | 2021-2022 | |
| Acacia Pharma INC | $40.67 | 2022 | |
| Janssen Biotech, INC. | $35.80 | 2025 | Stelara, Simponi, Simponi Aria |
| Pacira Pharmaceuticals Incorporated | $21.08 | 2022 | |
| Celltrion USA INC. | $20.24 | 2024 | Zymfentra |
| Regeneron Healthcare Solutions, INC. | $20.15 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Poulson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.